Company intelligence / Profile preview

Whitney Capital Series Fund LLC

Wilmington, Delaware, United States

Ownership: Private
Development stage: Other

Overview

Whitney Capital Series Fund LLC is a hedge fund operated by Schonfeld Strategic Advisors, registered in Delaware with ~$3.9 billion in assets, and headquartered in New York. It does not conduct biotech/pharma/healthcare operations, has no therapeutic product pipeline, and is not involved in clinical development. No healthcare partnerships, technologies, or research activities are linked to this entity.

Industry: Investors

Beyond the preview

Go deeper on Whitney Capital Series Fund LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Whitney Capital Series Fund LLC.

Explore the full profile